AMRN (Amarin Corporation plc) Stock Financials & Earnings | Market Cap Arena

AMRN (Amarin Corporation plc) Stock Financials & Earnings | Market Cap Arena

AMRNAmarin Corporation plc

Mkt Cap$310M

Healthcare·Biotechnology·🇮🇪 Ireland·NASDAQ

Revenue (TTM)$184M

Net Income (TTM)-$39M

EPS (TTM)-$1.81

Free Cash Flow (TTM)-$66,440

Gross Margin65.7%

Op. Margin-12.7%

Net Margin-21.1%

FCF Margin-0.0%

P/S Ratio (TTM)1.7x

P/E Ratio (TTM)—

YoY Rev Growth-19.6%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$86M	$48M	-$17M
Q2 23	$80M	$43M	-$24M
Q3 23	$66M	$30M	-$21M
Q4 23	$75M	$45M	-$5M
Q1 24	$57M	$32M	-$14M
Q2 24	$68M	$42M	-$525K
Q3 24	$42M	$16M	-$25M
Q4 24	$62M	-$10M	-$53M
Q1 25	$42M	$25M	-$17M
Q2 25	$73M	$50M	-$16M
Q3 25	$50M	$22M	-$11M
Q4 25	$19M	$23M	$20M

Valuation

Quarter	P/S	P/E
Q1 23	0.9x	—
Q2 23	0.9x	—
Q3 23	1.0x	—
Q4 23	1.0x	—
Q1 24	1.1x	—
Q2 24	1.2x	—
Q3 24	1.3x	—
Q4 24	1.4x	—
Q1 25	1.4x	—
Q2 25	1.4x	—
Q3 25	1.4x	—
Q4 25	1.7x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$7M	$0
Q2 23	$7M	$0
Q3 23	$7M	$7M
Q4 23	-$652K	-$652K
Q1 24	-$13M	-$13M
Q2 24	-$3M	-$3M
Q3 24	-$2M	-$2M
Q4 24	-$13M	-$13M
Q1 25	-$12M	-$12M
Q2 25	$17M	$17M
Q3 25	-$13M	-$13M
Q4 25	$9M	$9M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$7M
Q2 23	$7M
Q3 23	$961
Q4 23	$14
Q1 24	$4
Q2 24	$4
Q3 24	$3
Q4 24	$3
Q1 25	$0
Q2 25	$0
Q3 25	$4
Q4 25	$0

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	-9.1%	-16.0%
Q2 23	-15.1%	-33.8%
Q3 23	-26.5%	-7.9%
Q4 23	-16.5%	-19.9%
Q1 24	-34.3%	-32.1%
Q2 24	-15.7%	-34.6%
Q3 24	-36.0%	-22.9%
Q4 24	-17.3%	+43.5%
Q1 25	-25.7%	-16.2%
Q2 25	+7.7%	+30.3%
Q3 25	+17.4%	-9.9%
Q4 25	-68.8%	-100.9%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$0	0.0%
Q2 23	$0	0.0%
Q3 23	$0	0.0%
Q4 23	$0	0.0%
Q1 24	$0	0.0%
Q2 24	$0	0.0%
Q3 24	$0	0.0%
Q4 24	$0	0.0%
Q1 25	$4M	10.3%
Q2 25	$6M	8.3%
Q3 25	$0	0.0%
Q4 25	-$12M	-63.4%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 23	$6M	$27M	$32M	—
Q2 23	$6M	$19M	$32M	—
Q3 23	$5M	$21M	$24M	—
Q4 23	$5M	—	—	$44M
Q1 24	$6M	$19M	$20M	—
Q2 24	$4M	—	—	$39M
Q3 24	$5M	$18M	$19M	—
Q4 24	$6M	$17M	$20M	—
Q1 25	$5M	$20M	$17M	—
Q2 25	$5M	$24M	$15M	—
Q3 25	$4M	$14M	$5M	—
Q4 25	$5M	—	—	$20M

Revenue Segments

Quarter	Licensing And Royalty	Product
Q1 23	$1M	$85M
Q2 23	$15M	$65M
Q3 23	$1M	$65M
Q4 23	$4M	$71M
Q1 24	$1M	$55M
Q2 24	$20M	$48M
Q3 24	$446K	$42M
Q4 24	$2M	$60M
Q1 25	$982K	$41M
Q2 25	$26M	$47M
Q3 25	$1M	$49M

Revenue by Geography

Quarter	Europe	United States
Q1 25	$5M	$36M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$191M	$113M	$304M
Q2 23	$233M	$80M	$313M
Q3 23	$271M	$50M	$321M
Q4 23	$199M	$121M	$321M
Q1 24	$214M	$94M	$309M
Q2 24	$216M	$91M	$307M
Q3 24	$157M	$149M	$306M
Q4 24	$121M	$173M	$294M
Q1 25	$120M	$162M	$282M
Q2 25	$148M	$151M	$299M
Q3 25	$123M	$164M	$287M
Q4 25	$135M	$168M	$303M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	20M	+1.1%
Q2 23	20M	+0.4%
Q3 23	20M	+0.1%
Q4 23	20M	+0.0%
Q1 24	21M	+0.4%
Q2 24	21M	+0.3%
Q3 24	21M	-0.1%
Q4 24	21M	-0.1%
Q1 25	21M	+0.4%
Q2 25	21M	+0.4%
Q3 25	21M	+0.3%
Q4 25	416M	+1902.3%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$270K	201
FY 15	$389K	210
FY 16	$605K	215
FY 17	$751K	241
FY 18	$432K	530
FY 19	$445K	965
FY 20	$614K	1K
FY 21	$1M	560
FY 22	$1M	365
FY 23	$1M	275
FY 24	$831K	275
FY 25	$2M	80